| pubmed-article:6693669 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6693669 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:6693669 | lifeskim:mentions | umls-concept:C0021083 | lld:lifeskim |
| pubmed-article:6693669 | lifeskim:mentions | umls-concept:C0042479 | lld:lifeskim |
| pubmed-article:6693669 | lifeskim:mentions | umls-concept:C0855856 | lld:lifeskim |
| pubmed-article:6693669 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:6693669 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:6693669 | pubmed:issue | 1 Pt 1 | lld:pubmed |
| pubmed-article:6693669 | pubmed:dateCreated | 1984-3-5 | lld:pubmed |
| pubmed-article:6693669 | pubmed:abstractText | Twenty-eight of 62 children (45%) with a history of sting-induced anaphylaxis and initially positive skin tests to venom(s) developed negative venom skin tests to one or more of the venoms used in their treatment after 3 yr or more of immunotherapy. Children who developed negative venom skin tests were less sensitive prior to treatment, as judged by venom skin tests and venom-specific IgE antibody determinations, than children who maintained positive venom skin tests. Levels of venom-specific IgE antibodies declined with time in most children, but to lower levels in those with negative skin tests. Venom-specific IgG antibody levels were similar in both patients with negative skin tests and those with persistently positive skin tests. The development of negative skin tests may reflect a loss of allergic sensitivity, which is sufficient to allow the physician to consider the discontinuation of venom injections. | lld:pubmed |
| pubmed-article:6693669 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6693669 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6693669 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6693669 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:6693669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6693669 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6693669 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6693669 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:6693669 | pubmed:issn | 0091-6749 | lld:pubmed |
| pubmed-article:6693669 | pubmed:author | pubmed-author:ValentineM... | lld:pubmed |
| pubmed-article:6693669 | pubmed:author | pubmed-author:LichtensteinL... | lld:pubmed |
| pubmed-article:6693669 | pubmed:author | pubmed-author:NivYY | lld:pubmed |
| pubmed-article:6693669 | pubmed:author | pubmed-author:Kagey-Sobotka... | lld:pubmed |
| pubmed-article:6693669 | pubmed:author | pubmed-author:SchuberthK... | lld:pubmed |
| pubmed-article:6693669 | pubmed:author | pubmed-author:GraftD FDF | lld:pubmed |
| pubmed-article:6693669 | pubmed:author | pubmed-author:KwiterovichK... | lld:pubmed |
| pubmed-article:6693669 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6693669 | pubmed:volume | 73 | lld:pubmed |
| pubmed-article:6693669 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6693669 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6693669 | pubmed:pagination | 61-8 | lld:pubmed |
| pubmed-article:6693669 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:meshHeading | pubmed-meshheading:6693669-... | lld:pubmed |
| pubmed-article:6693669 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6693669 | pubmed:articleTitle | The development of negative skin tests in children treated with venom immunotherapy. | lld:pubmed |
| pubmed-article:6693669 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6693669 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
